Susan M Kansagra1, Vikki Papadouka, Anita Geevarughese, Michael A Hansen, Kevin J Konty, Jane R Zucker. 1. Susan M. Kansagra, Vikki Papadouka, Anita Geevarughese, and Kevin J. Konty are with and Michael A. Hansen was with the New York City Department of Health and Mental Hygiene, New York City, NY. Jane R. Zucker is with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, assigned to the Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, NY.
Abstract
OBJECTIVES: We determined the success of the school-located vaccination (SLV) program, implemented in 2009 in New York City to deliver pandemic influenza A (H1N1) monovalent vaccine (pH1N1), versus provider offices in reaching children who had never previously received influenza vaccine. METHODS: We compared the immunization history of children vaccinated in school versus provider offices. We included records in the Citywide Immunization Registry with pH1N1 administered between October 2009 and March 2010 to elementary school-aged children. RESULTS: In total, 96,524 children received pH1N1 vaccine in schools, and 102,933 children received pH1N1 vaccine in provider offices. Of children vaccinated in schools, 34% had never received seasonal influenza vaccination in the past, compared with only 10% of children vaccinated at provider offices (P < .001). Children vaccinated in schools were more likely to have received a second dose of pH1N1 in 2009-2010 than those vaccinated in provider offices (80% vs 45%). CONCLUSIONS: The SLV program was more successful at reaching children who had never received influenza immunization in the past and should be considered as a strategy for delivering influenza vaccine in routine and emergency situations.
OBJECTIVES: We determined the success of the school-located vaccination (SLV) program, implemented in 2009 in New York City to deliver pandemic influenza A (H1N1) monovalent vaccine (pH1N1), versus provider offices in reaching children who had never previously received influenza vaccine. METHODS: We compared the immunization history of children vaccinated in school versus provider offices. We included records in the Citywide Immunization Registry with pH1N1 administered between October 2009 and March 2010 to elementary school-aged children. RESULTS: In total, 96,524 children received pH1N1 vaccine in schools, and 102,933 children received pH1N1 vaccine in provider offices. Of children vaccinated in schools, 34% had never received seasonal influenza vaccination in the past, compared with only 10% of children vaccinated at provider offices (P < .001). Children vaccinated in schools were more likely to have received a second dose of pH1N1 in 2009-2010 than those vaccinated in provider offices (80% vs 45%). CONCLUSIONS: The SLV program was more successful at reaching children who had never received influenza immunization in the past and should be considered as a strategy for delivering influenza vaccine in routine and emergency situations.
Authors: Derek Weycker; John Edelsberg; M Elizabeth Halloran; Ira M Longini; Azhar Nizam; Vincent Ciuryla; Gerry Oster Journal: Vaccine Date: 2005-01-26 Impact factor: 3.641
Authors: Anthony E Fiore; David K Shay; Karen Broder; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox Journal: MMWR Recomm Rep Date: 2009-07-31
Authors: Anne Rinchiuso-Hasselmann; Ryan L McKay; Christopher A Williams; David T Starr; Beth Maldin Morgenthau; Jane R Zucker; Marisa Raphael Journal: Biosecur Bioterror Date: 2011-03-01
Authors: Mark Loeb; Margaret L Russell; Lorraine Moss; Kevin Fonseca; Julie Fox; David J D Earn; Fred Aoki; Gregory Horsman; Paul Van Caeseele; Khami Chokani; Mark Vooght; Lorne Babiuk; Richard Webby; Stephen D Walter Journal: JAMA Date: 2010-03-10 Impact factor: 56.272
Authors: Paul V Effler; Carl Chu; Howard He; Kate Gaynor; Steve Sakamoto; Marcia Nagao; Lisa Mendez; Sarah Y Park Journal: Emerg Infect Dis Date: 2010-02 Impact factor: 6.883
Authors: Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni Journal: J Prev Med Hyg Date: 2021-09-10
Authors: Shannon E MacDonald; Margaret L Russell; Xianfang C Liu; Kimberley A Simmonds; Diane L Lorenzetti; Heather Sharpe; Jill Svenson; Lawrence W Svenson Journal: Hum Vaccin Immunother Date: 2018-12-20 Impact factor: 3.452